
The United States government has a patent on cannabinoids as anti-oxidant for auto-immune diseases, and as neuroprotectants for treatment of Alzheimer’s disease, Parkinson’s disease, and HIV dementia.
The United States government has a patent on cannabinoids as anti-oxidant for auto-immune diseases, and as neuroprotectants for treatment of Alzheimer’s disease, Parkinson’s disease, and HIV dementia.